// App-Quantinova.ai

8383 : Treatment of Acute Optic Neuritis and MS Relapses: A Survey of Clinician Attitudes, Perspectives, and Clinical Reasoning

Researchers

Presenter

  • Emily M Schorr

Principal Investigators

  • Alexander Brandt

  • Vivek Patel

  • Laura Balcer

  • June Halper

  • Mark S Freedman

  • Friedemann Paul

  • Pablo Villoslada

  • Ann Yeh

  • Robert A Bermel

  • Axel Petzold

  • Jennifer Graves

  • Philipp Albrecht

  • Rachel Nolan-Kenney

  • Peter Calabresi

  • Ellen M Mowry

  • Scott D. Newsome

  • Kathryn C Fitzgerald

  • Shiv Saidha

Medical Centers

  • Department of Medicine and the Ottawa Hospital Research Institute, University of Ottawa, Ottawa, ON, Canada

  • Div. of Neuro-Ophthalmology, USC Roski Eye Inst., Keck School of Medicine, Los Angeles, CA

  • Dept. of Neurology, University of California, Irvine, School of Medicine, Irvine, CA

  • Consortium of Multiple Sclerosis Centers, Hackensack, NJ

  • Dept. of Neurology, Johns Hopkins School of Medicine, Baltimore, MD

  • Dept of Radiology, University of California, San Diego, San Diego, CA, USA

  • Dept. of Paediatrics, Div. of Neurology, The Hospital for Sick Children, Toronto, ON, Canada

  • 6Department of Neurology, Heinrich Heine University Duesseldorf Dusseldorf Germany

  • Dept. of Psychiatry and Behavioural Sciences & Dept. of Neurology and Neurological Sciences, Stanford University, Stanford, CA

  • Experimental Clinical Research Center, Max-Delbrück Center for Molecular Medicine and Charité-Universitätsmedizin Berlin Berlin Germany

  • UCL Institute of Neurology, London, England, United Kingdom

  • Dept. of Neurology, New York University Grossman School of Medicine, New York, NY

  • Mellen Center, Cleveland Clinic, Cleveland, OH

Locations

  • Germany

  • United States

  • Canada

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Methylprednisolone

  • Prednisone

  • IVIG

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final